Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

BACKGROUND: The effectiveness of reintroducing oxaliplatin in patients with metastatic colorectal cancer refractory to standard chemotherapy has not been verified. We performed a single-arm, open-label, Phase II study to evaluate the safety and efficacy of reintroducing oxaliplatin. METHODS: Eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Yamaguchi, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476424/
https://www.ncbi.nlm.nih.gov/pubmed/26124634
http://dx.doi.org/10.2147/DDDT.S85567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476424/
https://www.ncbi.nlm.nih.gov/pubmed/26124634
http://dx.doi.org/10.2147/DDDT.S85567

Ejemplares similares